165315-68-4Relevant articles and documents
Pyridine-substituted desoxyritonavir is a more potent inhibitor of cytochrome P450 3A4 than ritonavir
Sevrioukova, Irina F.,Poulos, Thomas L.
supporting information, p. 3733 - 3741 (2013/06/27)
Utilization of the cytochrome P450 3A4 (CYP3A4) inhibitor ritonavir as a pharmacoenhancer for anti-HIV drugs revolutionized the treatment of HIV infection. However, owing to ritonavir-related complications, there is a need for development of new CYP3A4 in